Development of Dl1.72, a Novel Anti-DLL1 Antibody with Anti-Tumor Efficacy against Estrogen Receptor-Positive Breast Cancer.
Silva G, Sales-Dias J, Casal D, Alves S, Domenici G, Barreto C, Matos C, Lemos AR, Matias AT, Kucheryava K, Ferreira A, Moita MR, Braga S, Brito C, Cabral MG, Casalou C, Barral DC, Sousa PMF, Videira PA, Bandeiras TM, Barbas A.
Silva G, et al. Among authors: casalou c.
Cancers (Basel). 2021 Aug 13;13(16):4074. doi: 10.3390/cancers13164074.
Cancers (Basel). 2021.
PMID: 34439228
Free PMC article.